We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeverfield Regulatory News (SFR)

Share Price Information for Severfield (SFR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 67.80
Bid: 67.00
Ask: 68.80
Change: -0.80 (-1.17%)
Spread: 1.80 (2.687%)
Open: 67.80
High: 69.00
Low: 67.00
Prev. Close: 68.60
SFR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Rump Placement

5 Apr 2013 10:10

RNS Number : 6738B
Severfield-Rowen PLC
05 April 2013
 



NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA OR JAPAN.

THIS ANNOUNCEMENT IS AN ADVERTISEMENT AND NOT A PROSPECTUS AND INVESTORS SHOULD NOT SUBSCRIBE FOR OR PURCHASE ANY SHARES OR SECURITIES REFERRED TO IN THIS ANNOUNCEMENT EXCEPT ON THE BASIS OF INFORMATION IN THE APPLICABLE PROSPECTUS WHICH, FOLLOWING APPROVAL FROM THE FINANCIAL SERVICES AUTHORITY, WAS PUBLISHED BY SEVERFIELD-ROWEN PLC ON 28 FEBRUARY 2013 IN CONNECTION WITH THE RIGHTS ISSUE.

 

5 April 2013

 

Severfield-Rowen PLC

 

Result of Rump Placement

 

Following the announcement earlier today regarding valid acceptances received under the Rights Issue, Severfield-Rowen Plc ("Severfield-Rowen" or "the Company") is pleased to announce that Jefferies International Limited ("Jefferies") has today procured subscribers for the remaining New Ordinary Shares for which valid acceptances were not received by 11.00 a.m. on 4 April 2013, at a price of 39 pence per New Ordinary Share.

 

Accordingly, neither Jefferies as underwriter nor any sub-underwriters procured by Jefferies will be required to subscribe for any New Ordinary Shares under the terms of the Underwriting Agreement.

 

Any premium over the total of the Issue Price of 23 pence per New Ordinary Share and the related expenses of procuring subscribers (including any applicable brokerage and other commissions and any amounts in respect of value added tax which are not recoverable) will be paid to Qualifying Shareholders that have not taken up their entitlements pro rata to their lapsed provisional allotments except that, in accordance with the terms and conditions of the Rights Issue, individual amounts of less than £5.00 will not be paid to such persons but will be retained for the benefit of the Company. Cheques are expected to be despatched on or around 12 April 2013.

 

Terms used in this announcement shall have the same meanings as set out in the Rights Issue prospectus dated 28 February 2013.

 

Severfield-Rowen Plc

John Dodds

Executive Chairman

 

Alan Dunsmore

Finance Director

 

01845 577896

 

 

 

 

Jefferies Hoare Govett

Simon Hardy

Lee Morton

Harry Nicholas

 

020 7029 8000

 

 

Pelham Bell Pottinger

Archie Berens

Guy Scarborough

 

 

020 7861 3112

020 7861 3870

 

Important notice:

 

This announcement does not constitute, or form part of any offer or invitation to purchase, otherwise acquire, subscribe for, sell, otherwise dispose of or issue, or any solicitation of any offer to sell, otherwise dispose of, issue, purchase, otherwise acquire or subscribe for, any security in the capital of the Company in any jurisdiction. Any decision to purchase, otherwise acquire, subscribe for, sell or otherwise dispose of any Provisional Allotment Letter, Nil Paid Rights, Fully Paid Rights and/or New Ordinary Shares should only be made on the basis of information contained in and incorporated by reference into the Prospectus which contains further details relating to the Company in general as well as a summary of the risk factors to which an investment in the New Ordinary Shares is subject. Nothing in this announcement should be interpreted as a term or condition of the Rights Issue.

Copies of the Prospectus are available from the Company's registered office and on the Company's website at www.sfrplc.com provided that the Prospectus is not available (whether though the website or otherwise) to Restricted Shareholders, subject to certain exceptions.

Subject to certain exceptions, the Prospectus is not available to shareholders located in the United States or any of Australia, Canada, Japan or the Republic of South Africa (the "Excluded Territories"). This announcement is not directed to, or intended for distribution or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, availability, or use would be contrary to law or regulation which would require any registration or licensing within such jurisdiction. The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.

This announcement does not constitute an offer of securities for sale in the United States. The securities referred to herein may not be offered or sold in the United States absent registration under the US Securities Act of 1933, as amended (the "US Securities Act"), or an exemption therefrom. The offer and sale of the securities referred to herein has not been and will not be registered under the US Securities Act or under the applicable securities laws of any Excluded Territory. There will be no public offer of the securities in the United States or any Excluded Territory. Subject to certain exceptions, the securities referred to herein may not be offered or sold in any Excluded Territory or to, or for the account or benefit of, any national, resident or citizen of an Excluded Territory.

Jefferies International Limited ("Jefferies"), which is authorised and regulated in the United Kingdom by the Financial Services Authority, is acting as sole sponsor and financial adviser for the Company and no one else in connection with the Rights Issue and will not regard any other person (whether or not a recipient of this announcement) as a client in relation to the Rights Issue and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for giving advice in connection with the Rights Issue, the contents of this announcement and the accompanying documents or any other transaction, arrangement or matter referred to herein or therein.

This announcement should not be considered a recommendation by Jefferies or any of its directors, officers, employees, advisers or any of their respective affiliates in relation to any purchase of or subscription for securities. No representation or warranty, express or implied, is given by or on behalf of any of Jefferies or any of its directors, officers, employees, advisers or any of their respective affiliates or any other person as to the accuracy, fairness, sufficiency or completeness of the information or the opinions or the beliefs contained in this announcement (or any part hereof). None of the information contained in this announcement has been independently verified or approved by Jefferies or any of its directors, officers, employees, advisers or any of their respective affiliates. Save in the case of fraud, no liability is accepted by Jefferies or any of its directors, officers, employees, advisers or any of their respective affiliates for any errors, omissions or inaccuracies in such information or opinions or for any loss, cost or damage suffered or incurred howsoever arising, directly or indirectly, from any use of this announcement or its contents or otherwise in connection with this announcement. No person has been authorised to give any information or to make any representations other than those contained in this announcement and, if given or made, such information or representations must not be relied on as having been authorised by the Company, Jefferies or any other person. Subject to the Listing Rules, the Prospectus Rules and the Disclosure and Transparency Rules, the issue of this announcement shall not, in any circumstances, create any implication that there has been no change in the affairs of the Company and its group since the date of this announcement or that the information in it is correct as at any subsequent date.

Jefferies may, in accordance with applicable legal and regulatory provisions, engage in transactions in relation to Nil Paid Rights, Fully Paid Rights, Existing Ordinary Shares and/or New Ordinary Shares and/or related instruments for its own account for the purpose of hedging its underwriting exposure (if any) or otherwise. Moreover, subject to the terms of the Underwriting Agreement, Jefferies, or any of its affiliates acting as an investor for its or their own account(s) may subscribe for, retain, purchase or sell Nil Paid Rights, Fully Paid Rights, Provisional Allotment Letters and/or New Ordinary Shares and/or related investments for its or their own account(s) and in that capacity may offer or sell such securities and/or other investments otherwise than in connection with the Rights Issue. Accordingly, references in this document to New Ordinary Shares being offered or placed should be read as including any offering or placement of New Ordinary Shares to Jefferies or any of its affiliates acting in such capacity. The aforementioned entities do not intend to disclose the extent of any such investments or transactions otherwise than in accordance with any applicable legal or regulatory requirements.

This announcement includes forward-looking statements within the meaning of the securities laws of certain jurisdictions. These forward-looking statements include, but are not limited to, statements other than statements of historical fact including without limitation, those regarding the Company's intentions, beliefs or current expectations concerning, among other things, the Company's results of operations, financial condition, prospects, growth, strategies and the industry in which the Company operates. Forward-looking statements are typically identified by the use of forward-looking terminology such as "believes", "expects", "may", "will", "could", "should", "shall", "risk", "intends", "estimates", "plans", "predicts", "continues", "assumes", "positioned" or "anticipates" or the negative thereof or other variations thereon or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. By their nature, forward-looking statements involve risks and uncertainties, including, without limitation, the risks and uncertainties to be set forth in the Prospectus, because they relate to events and depend on circumstances that may or may not occur in the future; actual events or results may differ materially from those expressed in or implied by these statements as a result of risks and uncertainties facing the Company and its subsidiaries. Many of these risks and uncertainties relate to factors that are beyond the Company's ability to control or estimate precisely, such as changes in future market conditions, currency fluctuations, the behaviour of other market participants, the actions of governmental regulators and other risk factors such as changes in the political, social and regulatory framework in which the Company operates or in economic or technological trends or conditions, including inflation and consumer confidence, on a global, regional or national basis. Such risks and uncertainties could cause actual results to vary materially from the future results indicated, expressed or implied in such forward-looking statements. The forward-looking statements contained in this announcement speak only as of the date of this announcement and the Company disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement to reflect any changes in its expectations or any changes in events, conditions or circumstances on which such statements are based unless required to do so by applicable law, the Prospectus Rules, the Listing Rules or the Disclosure Rules and Transparency Rules of the Financial Services Authority.

No statement in this announcement is intended as a profit forecast or a profit estimate and no statement in this announcement should be interpreted to mean that earnings per Ordinary Share for the current or future financial years would necessarily match or exceed the historical published earnings per Ordinary Share. Prices and values of, and income from, shares may go down as well as up and an investor may not get back the amount invested. It should be noted that past performance is no guide to future performance. Persons needing advice should consult an independent financial adviser.

Neither the content of the Company's website (or any other website) nor the content of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.

This announcement has been prepared for the purposes of complying with applicable law and regulation in the United Kingdom and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws and regulations of any jurisdiction outside of the United Kingdom.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFIASIIEIIV
Date   Source Headline
2nd May 20244:08 pmRNSBlock listing six monthly return
2nd May 202412:08 pmRNSVoting Rights and Share Capital Update
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:14 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSChairman appointment
17th Apr 20247:00 amRNSTrading Statement
15th Apr 20247:53 amRNSProgressive publish new research
21st Mar 20245:35 pmRNSPDMR Shareholding
19th Feb 20241:58 pmRNSStandard form for notification of major holdings
8th Feb 20247:00 amRNSCDP ‘A List’ for climate change
18th Dec 20231:43 pmRNSDirector/PDMR Shareholding
21st Nov 20238:02 amRNSProgressive publishes new research
21st Nov 20237:00 amRNSInterim Results
6th Nov 20237:00 amRNSNotice of Investor Presentation
9th Oct 20232:46 pmRNSNotification of Transactions of Directors
18th Sep 20234:08 pmRNSRSP grant
6th Sep 20238:54 amRNSProgressive publishes new research
6th Sep 20237:00 amRNSAGM trading update
7th Aug 202312:12 pmRNSNotice of Annual General Meeting and Annual Report
31st Jul 20233:18 pmRNSDirector/PDMR Shareholding
31st Jul 20231:18 pmRNSDirectorate Change
26th Jul 20237:00 amRNSDirectorate Change
14th Jun 20237:00 amRNSNotice of Results and Investor Presentation
14th Jun 20237:00 amRNSFinal Results
18th May 202311:13 amRNSTotal Voting Rights
28th Apr 20237:35 amRNSProgressive publishes Spotlight note
3rd Apr 20232:11 pmRNSCompletion of Acquisition
27th Mar 20237:00 amRNSTrading Statement
21st Mar 202311:03 amRNSNotification of Major Holdings
16th Mar 202312:18 pmRNSProgressive publishes new research
15th Mar 20237:00 amRNSAcquisition
24th Jan 20234:40 pmRNSSecond Price Monitoring Extn
24th Jan 20234:35 pmRNSPrice Monitoring Extension
22nd Dec 20224:40 pmRNSSecond Price Monitoring Extn
22nd Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 20221:14 pmRNSDirector/PDMR Shareholding
2nd Dec 202210:19 amRNSNOTICE OF CHANGE TO DIRECTOR DETAILS
22nd Nov 20227:30 amRNSProgressive publishes new research
22nd Nov 20227:00 amRNSInterim Results
9th Nov 20224:41 pmRNSSecond Price Monitoring Extn
9th Nov 20224:36 pmRNSPrice Monitoring Extension
26th Oct 20227:39 amRNSProgressive publishes new research
17th Oct 20224:36 pmRNSPrice Monitoring Extension
13th Oct 20228:27 amRNSDirector/PDMR Shareholding
3rd Oct 202210:16 amRNSDirectorate Change - Replacement
3rd Oct 20227:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.